Syngene International Ltd.
₹422.2-0.87%Feb 27, 3:45 PM IST
SYNGENE•Commercial Services•Miscellaneous Commercial Services
Current Price
₹422.2-0.87%
Feb 27, 3:45 PM ISTMarket Cap₹17,149.1 Cr
Market Cap₹17,149.1 Cr
Business Overview
Syngene International Limited operates through 4 main business divisions including Discovery Services, Development Services, Dedicated R&D Centers, Manufacturing Services.
Business Hierarchy Structure for Syngene International Limited
- Syngene International Limited
- Discovery Services
- Capabilities
- Chemistry
- Biology
- Safety Assessment
- Computational and Data Sciences
- Modalities & Specialties
- Traditional small molecule therapeutics
- Biologics
- Peptides
- Oligonucleotides
- Antibody-drug conjugates
- Targeted degradation/stabilization
- Platforms
- Syngene SynVent™ (Integrated Drug Discovery)
- Capabilities
- Development Services
- Focus
- Small Molecules
- Services
- Drug Substance Development
- Drug Product Development
- Pre-clinical to Clinical Trials
- Safety, Tolerability, and Efficacy Demonstration
- Therapeutic Modalities
- Highly Potent Active Pharmaceutical Ingredients (HPAPIs)
- Oligonucleotides (for therapeutic and diagnostic applications)
- Expertise
- Synthetic Organic Chemistry
- Polymer Chemistry
- Performance Chemicals
- Specialty Materials
- Integrated Services
- Analytical Services (Method Development, Validation, Transfer, Reference Standard Qualification)
- Focus
- Dedicated R&D Centers
- Service Model: Turnkey Solution for Dedicated Research Centers
- Client Collaborations
- Amgen
- Baxter
- Bristol Myers Squibb
- Manufacturing Services
- Focus: Commercial-Scale Manufacturing
- Molecule Types
- Small Molecules
- API Manufacturing (Mangalore Facility)
- Large Molecules (Biologics)
- Biologics Manufacturing (Bangalore Facility)
- Multi-modal Biologics Manufacturing Facility (Acquired, expected operational 2024)
- Small Molecules
- Services
- Drug Substance Manufacturing
- Drug Product Manufacturing (Commercial Scale Fill-Finish)
- Discovery Services